156 related articles for article (PubMed ID: 21125333)
1. Proteomic identification of differentially-expressed proteins in esophageal cancer in three ethnic groups in Xinjiang.
Liu Z; Feng JG; Tuersun A; Liu T; Liu H; Liu Q; Zheng ST; Huang CG; Lv GD; Sheyhidin I; Lu XM
Mol Biol Rep; 2011 Jun; 38(5):3261-9. PubMed ID: 21125333
[TBL] [Abstract][Full Text] [Related]
2. Under-expression of annexin A2 is associated with Kazakh's esophageal squamous cell carcinoma.
Li X; Zheng S; Liu Q; Liu T; Liang M; Gao X; Lu M; Sheyhidin I; Lu X
Mol Carcinog; 2015 Sep; 54(9):779-88. PubMed ID: 24668792
[TBL] [Abstract][Full Text] [Related]
3. Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma.
Zhang J; Wang K; Zhang J; Liu SS; Dai L; Zhang JY
J Proteome Res; 2011 Jun; 10(6):2863-72. PubMed ID: 21517111
[TBL] [Abstract][Full Text] [Related]
4. Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis.
Zhu X; Ding M; Yu ML; Feng MX; Tan LJ; Zhao FK
BMC Cancer; 2010 Jun; 10():290. PubMed ID: 20546628
[TBL] [Abstract][Full Text] [Related]
5. M2 isoform of pyruvate kinase (PKM2) is upregulated in Kazakh's ESCC and promotes proliferation and migration of ESCC cells.
Liu Q; Liang M; Liu T; Vuitton L; Zheng S; Gao X; Lu M; Li X; Sheyhidin I; Lu X
Tumour Biol; 2016 Feb; 37(2):2665-72. PubMed ID: 26404132
[TBL] [Abstract][Full Text] [Related]
6. Proteomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma.
Du XL; Hu H; Lin DC; Xia SH; Shen XM; Zhang Y; Luo ML; Feng YB; Cai Y; Xu X; Han YL; Zhan QM; Wang MR
J Mol Med (Berl); 2007 Aug; 85(8):863-75. PubMed ID: 17318615
[TBL] [Abstract][Full Text] [Related]
7. Proteomic identification of differentially-expressed proteins in squamous cervical cancer.
Zhu X; Lv J; Yu L; Zhu X; Wu J; Zou S; Jiang S
Gynecol Oncol; 2009 Jan; 112(1):248-56. PubMed ID: 19007971
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological pattern and Annexin A2 and Cdc42 status in patients presenting with differentiation and lymphnode metastasis of esophageal squamous cell carcinomas.
Feng JG; Liu Q; Qin X; Geng YH; Zheng ST; Liu T; Sheyhidin I; Lu XM
Mol Biol Rep; 2012 Feb; 39(2):1267-74. PubMed ID: 21603851
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis indicates the importance of TPM3 in esophageal squamous cell carcinoma invasion and metastasis.
Yu SB; Gao Q; Lin WW; Kang MQ
Mol Med Rep; 2017 Mar; 15(3):1236-1242. PubMed ID: 28138712
[TBL] [Abstract][Full Text] [Related]
10. Identification of alpha-actinin 4 and 67 kDa laminin receptor as stage-specific markers in esophageal cancer via proteomic approaches.
Fu L; Qin YR; Xie D; Chow HY; Ngai SM; Kwong DL; Li Y; Guan XY
Cancer; 2007 Dec; 110(12):2672-81. PubMed ID: 17960614
[TBL] [Abstract][Full Text] [Related]
11. [Application of serum proteomic patterns for the detection of esophageal carcinoma in Kazakh in Xinjiang].
Zhang CM; Zhang HP; Zhang Q; Zhang Z; Ma YQ; Sun QC; Ainiwaer J; Sheyhidin I
Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(3):171-4. PubMed ID: 21418897
[TBL] [Abstract][Full Text] [Related]
12. Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method.
Zhao J; Fan YX; Yang Y; Liu DL; Wu K; Wen FB; Zhang CY; Zhu DY; Zhao S
Int J Clin Exp Pathol; 2015; 8(2):1535-44. PubMed ID: 25973038
[TBL] [Abstract][Full Text] [Related]
13. Loss of clusterin both in serum and tissue correlates with the tumorigenesis of esophageal squamous cell carcinoma via proteomics approaches.
Zhang LY; Ying WT; Mao YS; He HZ; Liu Y; Wang HX; Liu F; Wang K; Zhang DC; Wang Y; Wu M; Qian XH; Zhao XH
World J Gastroenterol; 2003 Apr; 9(4):650-4. PubMed ID: 12679903
[TBL] [Abstract][Full Text] [Related]
14. Identification of PA28β as a potential novel biomarker in human esophageal squamous cell carcinoma.
Chen JY; Xu L; Fang WM; Han JY; Wang K; Zhu KS
Tumour Biol; 2017 Oct; 39(10):1010428317719780. PubMed ID: 29020885
[TBL] [Abstract][Full Text] [Related]
15. Comparative proteomic analysis of beta-catenin-mediated malignant progression of esophageal squamous cell carcinoma.
Ren HZ; Wang JS; Pan GQ; Lv H; Wen JF; Luo GQ; Wang KS; Zhang PF
Dis Esophagus; 2010 Feb; 23(2):175-84. PubMed ID: 19664078
[TBL] [Abstract][Full Text] [Related]
16. Identification of proteomic signatures associated with lung cancer and COPD.
Pastor MD; Nogal A; Molina-Pinelo S; Meléndez R; Salinas A; González De la Peña M; Martín-Juan J; Corral J; García-Carbonero R; Carnero A; Paz-Ares L
J Proteomics; 2013 Aug; 89():227-37. PubMed ID: 23665002
[TBL] [Abstract][Full Text] [Related]
17. Identification of differentially expressed proteins between human esophageal immortalized and carcinomatous cell lines by two-dimensional electrophoresis and MALDI-TOF-mass spectrometry.
Xiong XD; Xu LY; Shen ZY; Cai WJ; Luo JM; Han YL; Li EM
World J Gastroenterol; 2002 Oct; 8(5):777-81. PubMed ID: 12378614
[TBL] [Abstract][Full Text] [Related]
18. Protein clusters associated with carcinogenesis, histological differentiation and nodal metastasis in esophageal cancer.
Hatakeyama H; Kondo T; Fujii K; Nakanishi Y; Kato H; Fukuda S; Hirohashi S
Proteomics; 2006 Dec; 6(23):6300-16. PubMed ID: 17133371
[TBL] [Abstract][Full Text] [Related]
19. Analysis of XPD genetic polymorphisms of esophageal squamous cell carcinoma in a population of Yili Prefecture, in Xinjiang, China.
Huang CG; Liu T; Lv GD; Liu Q; Feng JG; Lu XM
Mol Biol Rep; 2012 Jan; 39(1):709-14. PubMed ID: 21553048
[TBL] [Abstract][Full Text] [Related]
20. SUMOylation of HSP27 regulates PKM2 to promote esophageal squamous cell carcinoma progression.
Zhang X; Liu T; Zheng S; Liu Q; Shen T; Han X; Zhang Q; Yang L; Lu X
Oncol Rep; 2020 Oct; 44(4):1355-1364. PubMed ID: 32945483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
